Newsfeeds Archive - Page 2 of 3

3 minute read

Crude Oil Down Over 2%; General Motors Posts Upbeat Earnings

October 24, 12:59 PM

U.S. stocks traded slightly higher midway through trading, with the Dow Jones index gaining around 50 points on Tuesday. The Dow traded up 0.17% to 32,992.95 while the NASDAQ rose 0.06% to 13,023.65. The S&P 500 also rose, gaining, 0.07% to 4,220.02.

ASTI

1 minute read

Why LianBio Stock Is Ripping Higher Today

By Erica Kollmann

October 24, 10:24 AM

LianBio (NASDAQ: LIAN) shares are trading higher Tuesday after the company announced an agreement with Bristol Myers Squibb (NYSE: BMY) to purchase LianBio's exclusive rights to develop and commercialize

BMY

3 minute read

Dow Surges 250 Points; US Manufacturing PMI Tops Expectations

By Lisa Levin

October 24, 10:14 AM

U.S. stocks traded higher this morning, with the Dow Jones index gaining over 250 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.80% to 33,200.75 while the NASDAQ rose 0.88% to 13,132.62. The S&P 500 also rose, gaining, 0.79% to 4,250.15.

AIRE

1 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Pre-Market Session

By Benzinga Insights

October 24, 9:06 AM

Gainers LianBio (NASDAQ:LIAN) stock increased by 79.8% to $2.5 during Tuesday’s pre-market session. The market value of their…

CTXR

2 minute read

LianBio Announces First Patient Treated In Phase 1 Trial Of SHP2 Inhibitor BBP-398 In Combination With Osimertinib In Patients With Non-Small Cell Lung Cancer With EGFR Mutations

By Benzinga Newsdesk

August 3, 5:23 PM

LianBio (NASDAQ:LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced the first patient has been dosed in its Phase 1 clinical

LIAN

4 minute read

Why NETGEAR Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

April 27, 12:48 PM

Gainers Evelo Biosciences, Inc. (NASDAQ: EVLO) jumped 147.9% to $0.2479. Evelo Biosciences shares dropped 33% on Wednesday after the company announced top-line data from the fourth cohort of its EDP1815 Phase 2 trial, in which the primary endpoint was not met.

ABBV

1 minute read

LianBio Touts Positive Data From Bristol Myers-Partnered Heart Drug In Chinese Patients

By Vandana Singh

April 26, 1:56 PM

LianBio (NASDAQ: LIAN) announced

BMY

4 minute read

LianBio Announces China National Medical Products Administration Acceptance With Priority Review Of New Drug Application For Mavacamten For The Treatment Of Patients With Obstructive Hypertrophic Cardiomyopathy

By Happy Mohamed

April 21, 8:06 AM

LianBio (NASDAQ:LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced that China's National Medical Products Administration

LIAN

1 minute read

Pfizer Opts In To LianBio Rights to Respiratory Syncytial Virus Candidate In Greater China

By Vandana Singh

December 19, 2:44 PM

Pfizer Inc (NYSE:PFE) has opted into the right to develop and commercialize LianBio’s (NASDAQ:LIAN) sisunatovir, a respiratory syncytial virus (RSV) therapeutic…

LIAN

1 minute read

Global
News

Pfizer Opts In To LianBio Rights To Respiratory Syncytial Virus Therapeutic Candidate Sisunatovir In Mainland China, Hong Kong, Macau, And Singapore

By Benzinga Newsdesk

December 19, 8:03 AM

Pfizer will now lead all development and commercialization activities in Mainland China, Hong Kong, Macau, and Singapore LianBio will receive a $20 million upfront payment, to be released from previously

LIAN